$GHRS News

GH Research (GHRS) Stock May Look Stretched As Book Value Trails Price

GH Research: 'Buy' GH001 TRD Advancement Presses On And Expansion Opportunities

Guggenheim Maintains Buy on GH Research, Raises Price Target to $40

Cantor Fitzgerald Maintains Overweight on GH Research, Raises Price Target to $40

Needham Maintains Buy on GH Research, Raises Price Target to $39

GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update

GH Research Q2 EPS $(0.23) Beats $(0.30) Estimate

Is GH Research (GHRS) Trading At A Premium To Fair Value?

Wells Fargo Initiates Coverage On GH Research with Overweight Rating, Announces Price Target of $44

H.C. Wainwright Maintains Buy Rating on GH Research (GHRS)

GH Research Announces Publication of Phase 2a Postpartum Depression Results

GH Research Announces Publication Of Full Results From Its Phase 2a Trial In Postpartum Depression

GH Research: Rapid Onset And Short Action Change The Treatment Paradigm

HC Wainwright & Co. Maintains Buy on GH Research, Lowers Price Target to $65

Assessing GH Research (GHRS) Valuation After Key Phase 2b Results And Phase 3 Trial Plans

These Analysts Revise Their Forecasts On GH Research After Q1 Results

Cantor Fitzgerald Maintains Overweight on GH Research, Raises Price Target to $35

Citizens Maintains Market Outperform on GH Research, Lowers Price Target to $39

GH Research Reports First Quarter 2026 Financial Results and Provides Business Update

GH Research Q1 EPS $(0.31) Misses $(0.28) Estimate